Flovent Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 500/50 Inhalation Powder/GSK in Healthy Volunteers
Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent;   Drug: ADVAIR DISKUS® 500/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   BECRO Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2020 Category: Research Source Type: clinical trials

A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 500/50 Inhalation Powder/GSK in Healthy Volunteers
Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent;   Drug: ADVAIR DISKUS® 500/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   BECRO Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2020 Category: Research Source Type: clinical trials